Fueling the Future with ‘Green’ Trades
[cnbc 3000084911] The Fast Money traders with the play on Capital One’s earnings, and Darren Jamison, Capstone Turbine president […]
[cnbc 3000084911] The Fast Money traders with the play on Capital One’s earnings, and Darren Jamison, Capstone Turbine president […]
[cnbc 3000084182] Charles Kantor, Neuberger Berman, discusses his strategy of buying growth stocks and high yield bonds to overcome a turbulent market. […]
[cnbc 3000085207] CNBC’s Jon Fortt reports the update from Microsoft’s earnings conference call, including the development of Windows 8 on Intel and ARM are both on schedule. […]
[cnbc 3000085211] The Fast Money crew with the after-hours play on SanDisk’s Q1 earnings, and the trade on homebuilders, with Nishu Sood, Deutsche Bank analyst, who discusses his upgrade of Toll Brothers to a “buy”. […]
[cnbc 3000085219] A fear trade on the VIX and Apple’s volatility, with Jon Najarian, optionMONSTER co-founder. […]
[cnbc 3000084667] The Fast Money traders weigh in on whether Chipotle is a buy, sell or hold, and a look at how investors should trade overbought momentum stocks, with Barry Sine, Drexel Hamilton director of research. […]
[cnbc 3000085278] CNBCs Scott Cohn reports a second U.S. attorney’s office is investigating another Goldman Sachs employee in the Rajat Gupta case. […]
[cnbc 3000084915] The Fast Money crew weighs in on Microsoft’s better-than-expected Q3 EPS of $0.60 on revenues of $17.41B. Colin Gillis, BGC Financial analyst, breaks down the tech giant’s earnings and how to play the stock. […]
[cnbc 3000085277] Shares of Apple fall over 3 percent. A significant drop in Q1 Verizon activations and concerns Apple may miss its Q2 iPhone targets weighs heavily on the stock, which is down 9 percent since its April 10th high. […]
[cnbc 3000085015] An options strategy to protect your long position on Apple, with Mike Khouw, CRT Capital Group. […]
[cnbc 3000085203] CNBC’s Simon Hobbs and the Fast Money traders discuss the day’s top trades and the stocks they’ll be watching tomorrow. […]
[cnbc 3000085274] The Fast Money traders weigh in on Thursday’s market action and the play on concerns Apple may miss its Q2 iPhone target. […]
[cnbc 3000085200] Peter Boockvar, Miller Tabak and Stuart Freeman, Wells Fargo Advisors, take two different positions on where the market currently stands and where it’s headed. […]
[youtube CBxBtK-2XJc] Follow Max Keiser on Twitter: http://twitter.com/maxkeiser In this episode, Max Keiser and co-host, Stacy Herbert discuss huddles and cuddles with the Goombahs of Wall Street and the technical violations that cannot be called by name. In the second half of the show Max talks to Rolling Stone journalist, Matt Taibbi, about the Wall Street mafia, their small and big time rackets and the process of writing these crime stories for a wide audience. […]
[cnbc 3000085041] CNBC’s Michelle Caruso-Cabrera reports that the SEC expected to vote today on possible charges against Egan Jones. Willie Williams, Societe Generale, also discusses how today’s Spanish bond auction is impacting the global markets. […]
[cnbc 3000085042] Shares of chipmaker Qualcomm are down 4% today after the company reported disappointing economic reports. Discussing whether there is still quality in the company, with Glen Yeung, Citi Investment Research managing director. […]
[cnbc 3000085063] Human Genome Sciences rejected the $2.6 billion unsolicited takeover bid from GlaxoSmithKline, reports CNBC’s Herb Greenberg. […]
[cnbc 3000085064] The FMHR traders explain why they are trading Family Dollar, Yum! Brands and Southwest Airlines. Stephen Weiss, Short Hills Capital, also breaks down why he says investors should buy Qualcomm. […]
[cnbc 3000085065] The FMHR traders discuss Wednesday’s impressive earnings data from VMware and F-5 Networks. Rob Breza, Enterprise software analyst, also explains why investors should buy Microsoft. […]
[cnbc 3000085212] CNBC’s Herb Greenberg looks at why several analysts covering Mylan may have cut their first quarter earnings estimates within a few days of each other, citing concerns about the anti-depressant Lexapro. Herb’s question: ‘Did the company engage in some kind of selective disclosure?’ […]
Copyright © 2024 | MH Magazine WordPress Theme by MH Themes